SCHEMBL30295883

SCHEMBL30295883

CCCCC(CC)Cc1cnc(N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)c(Cl)c1SOC(=O)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30296200 0.82 ALDH1A1 (0.35) —
SCHEMBL30295953 0.80 ALDH1A1 (0.34) —
SCHEMBL30295996 0.79 ALDH1A1 (0.33) —
SCHEMBL30295962 0.72 ACACB (0.33) —
SCHEMBL30295767 0.72 MERTK (0.35) —
SCHEMBL21154735 0.69 CYP3A4 (0.41) —
Hydrogen Sulfide SCHEMBL29041447 0.68 CYP3A4 (0.42) —
SCHEMBL22259299 0.61 THRB (0.36) —
SCHEMBL29498374 0.61 THRB (0.36) —
SCHEMBL26975107 0.60 MAPKAPK2 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109983001-B 2, 5-disubstituted 3-methylpyrazines and 2,5, 6-trisubstituted 3-methylpyrazines as allosteric SHP2 inhibitors 锐新医药公司 2023-04-04 — — CN disclosed
Send feedback